HIV treatment: latest news

HIV treatment resources

HIV treatment features

HIV treatment in your own words

HIV treatment news from aidsmap

More news

HIV treatment news selected from other sources

  • PREZCOBIX™ now available for Canadians living with HIV

    Janssen Inc. announced today that PREZCOBIX™ (darunavir/cobicistat), a once-daily, oral medication for the treatment of HIV infection in combination with other antiretroviral agents, is now available in Canada. The new treatment option combining a protease inhibitor with a boosting agent reduces the number of pills required to manage HIV.

    18 September 2014 | Newswire.ca
  • CDC Launches HIV Treatment Awareness Campaign

    “HIV Treatment Works” is a new awareness campaign from the U.S. Centers for Disease Control and Prevention (CDC).

    17 September 2014 | Poz
  • Long acting HIV drugs to be developed

    HIV drugs which only need to be taken once a month are to be developed at the University of Liverpool in a bid to overcome the problem of ‘pill fatigue’.

    15 September 2014 | University of Liverpool press release
  • Uganda: Aids Patients Reject Bitter ARVs

    The Uganda Coalition for Access to Essential Medicine (UCAEM) has asked government to withdraw and cease use of non-film coated tenofovir and lamivudine, dubbing the drug combination as notoriously bitter. "People living with HIV will more likely stop taking treatment than use this medicine," said Margaret Happy, the advocacy officer of the International Community of Women in East Africa (ICWEA).

    10 September 2014 | Allafrica.com
  • New Tenofovir Alafenamide Combo Pill Has Less Effect on Kidneys and Bones

    An experimental single-tablet regimen containing a new version of tenofovir (tenofovir alafenamide or TAF) and the HIV protease inhibitor darunavir (Prezista) worked as well as a similar regimen containing the older tenofovir disoproxil fumarate (TDF) formulation,but it had less detrimental effects on kidney function and bone density, as study presented at the recent ICAAC conference heard.

    09 September 2014 | HIVandhepatitis.com
  • EU marketing authorization for ViiV Healthcare HIV drug Triumeq

    The European Commission has granted marketing authorization for ViiV Healthcare’s Triumeq(dolutegravir 50mg/abacavir 600mg/lamivudine 300mg) tablets for the treatment of HIV in adults and adolescents aged 12 years and older.

    04 September 2014 | Pharma Letter
  • Malawi First Country to Put HIV Positive Pregnant Women On ARVs

    President Arthur Peter Mutharika says Malawi was the first country to adopt a policy of putting all HIV positive pregnant and breast feeding women on anti-retroviral (ARV) drugs regardless of their CD4 Count.

    02 September 2014 | AllAfrica
  • Protein tethers HIV and Ebola to cells

    A family of proteins that helps viruses, such as HIV and Ebola, enter a cell also can block the release of those viruses. When HIV-1 or any virus infects a cell, it replicates and spreads to other cells. One type of cellular protein—T cell immunoglobulin and mucin domain, or TIM-1—has previously been shown to promote entry of some highly pathogenic viruses into host cells. Researchers have now discovered that the same protein possesses a unique ability to block the release of such viruses. The findings are published in the Proceedings of the National Academy of Sciences. “This is a surprising finding that provides new insights into our understanding of not only HIV infection, but also that of Ebola and other viruses,” says Shan-Lu Liu, associate professor of molecular microbiology and immunology at University of Missouri.

    26 August 2014 | Futurity
  • Zambia: PMTCT Real Life Story

    The pain of living through the loss of three children was enough to discourage Constance Mudenda from ever contemplating parenting. When she was pregnant, her greatest desire was to have a child born free of HIV, and now she will continue to mentor her daughter to ensure she is protected from acquiring HIV.

    21 August 2014 | Times of Zambia
  • HIV drugs 'boost South African life expectancy'

    South Africans are living on average up to 61.2 years compared to 52.2 years nearly 10 years ago, mainly thanks to life-saving Aids drugs, a government report says.

    04 August 2014 | BBC
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.